menu
    • menu

    Company profile for Disc medicine

    NEW Drugs in Dev: 6
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic dise...
    Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic diseases. Our core development programs target hepcidin biology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Disc medicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Technology Square, Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.discmedicine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Disc Medicine Reports Positive Phase 2 Data in MF at ASCO 2026
    Disc Medicine Reports Positive Phase 2 Data in MF at ASCO 2026

    02 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/02/3305110/0/en/disc-medicine-presents-updated-positive-data-from-rally-mf-phase-2-trial-in-patients-with-myelofibrosis-mf-and-anemia-at-the-2026-american-society-of-clinical-oncology-asco-annual-.html

    GLOBENEWSWIRE
    02 Jun 2026
    Share Share
    Disc Medicine Initiates Expanded Access For Bitopertin In EPP
    Disc Medicine Initiates Expanded Access For Bitopertin In EPP

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304352/0/en/disc-medicine-launches-expanded-access-program-for-bitopertin-for-epp-patients.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Sciensus and Disc Medicine Showcase Rare Disease Survey Framework
    Sciensus and Disc Medicine Showcase Rare Disease Survey Framework

    19 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7448404

    FIRSTWORD PHARMA
    19 May 2026
    Share Share
    Disc Medicine Announces Portfolio Presentations at EHA
    Disc Medicine Announces Portfolio Presentations at EHA

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292994/0/en/disc-medicine-announces-multiple-presentations-across-portfolio-at-the-european-hematology-association-eha-2026-congress.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Disc Medicine to Participate in Upcoming Investor Conferences
    Disc Medicine to Participate in Upcoming Investor Conferences

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3291877/0/en/disc-medicine-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Disc Medicine Reports Q1 2026 Results and Updates
    Disc Medicine Reports Q1 2026 Results and Updates

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3287684/0/en/disc-medicine-reports-first-quarter-2026-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search